<DOC>
	<DOCNO>NCT02996396</DOCNO>
	<brief_summary>Multicenter , single arm , open label , registry study consecutive , eligible patient enrollment site . All subject undergo Endovascular Aneurysm Sealing System ( EVAS ) NellixÂ®-System . Subjects follow procedurally discharge , per institutional standard care thereafter 5 year ( total follow-up commitment )</brief_summary>
	<brief_title>Nellix Registry Study : EVAS-Global</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>1 . Male female least 18 year old 2 . Subject sign informed consent data release 3 . Subjects AAA eligible endovascular repair 1 . Currently participate another study primary endpoint reach yet 2 . Known allergy device component 3 . Pregnant ( female childbearing potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>AAA , Aortoiliac Aneurysm</keyword>
</DOC>